OBJECTIVE: In our study, the effects of glycosylated protein cross-link breaker, alagebrium was investigated on isolated rat carotid artery using myography. Alagebrium showed vasodilator effect on carotid artery rings; particularly, this effect was significantly increased in endothelium-intact rings. MATERIALS AND METHODS: To clarify the vasodilator mechanism of alagebrium, different antagonists such as N(G)-Nitro-L-arginine methyl ester (L-NAME), glibenclamide, indomethacin, metoprolol, propranolol, tetraethylammonium, and calcium channel activator BAYK-8644 were used to reverse this effect. RESULTS: Relaxation% responses to alagebrium were more significantly increased in intact endothelium than in denuded arteries. Blocking vasodilation related to channels (K-ATP, PGI2, BKca) and receptors (ß1, ß2) did not reverse the relaxation response to alagebrium. Vasodilator response to alagebrium was only slightly decreased after L-NAME incubation and significantly decreased after BAYK-8644 incubation. CONCLUSION: Results of present study suggest that the mechanism of alagebrium-induced vasodilator effect may include the blockage of L-type calcium channels and partially of the nitric oxide synthase enzyme.
OBJECTIVE: In our study, the effects of glycosylated protein cross-link breaker, alagebrium was investigated on isolated rat carotid artery using myography. Alagebrium showed vasodilator effect on carotid artery rings; particularly, this effect was significantly increased in endothelium-intact rings. MATERIALS AND METHODS: To clarify the vasodilator mechanism of alagebrium, different antagonists such as N(G)-Nitro-L-arginine methyl ester (L-NAME), glibenclamide, indomethacin, metoprolol, propranolol, tetraethylammonium, and calcium channel activator BAYK-8644 were used to reverse this effect. RESULTS: Relaxation% responses to alagebrium were more significantly increased in intact endothelium than in denuded arteries. Blocking vasodilation related to channels (K-ATP, PGI2, BKca) and receptors (ß1, ß2) did not reverse the relaxation response to alagebrium. Vasodilator response to alagebrium was only slightly decreased after L-NAME incubation and significantly decreased after BAYK-8644 incubation. CONCLUSION: Results of present study suggest that the mechanism of alagebrium-induced vasodilator effect may include the blockage of L-type calcium channels and partially of the nitric oxide synthase enzyme.
Authors: D A Kass; E P Shapiro; M Kawaguchi; A R Capriotti; A Scuteri; R C deGroof; E G Lakatta Journal: Circulation Date: 2001-09-25 Impact factor: 29.690
Authors: M T Goova; J Li; T Kislinger; W Qu; Y Lu; L G Bucciarelli; S Nowygrod; B M Wolf; X Caliste; S F Yan; D M Stern; A M Schmidt Journal: Am J Pathol Date: 2001-08 Impact factor: 4.307
Authors: Elisa Cairrão; Ezequiel Alvarez; João Miguel Carvas; Antonio Jose Santos-Silva; Ignacio Verde Journal: Acta Pharmacol Sin Date: 2012-04-02 Impact factor: 6.150
Authors: Jasper W L Hartog; Adriaan A Voors; Stephan J L Bakker; Andries J Smit; Dirk J van Veldhuisen Journal: Eur J Heart Fail Date: 2007-12 Impact factor: 15.534
Authors: Allyson L Kranstuber; Carlos Del Rio; Brandon J Biesiadecki; Robert L Hamlin; Joseph Ottobre; Sandor Gyorke; Véronique A Lacombe Journal: Front Physiol Date: 2012-07-19 Impact factor: 4.566
Authors: Vienna E Brunt; Abigail G Casso; Rachel A Gioscia-Ryan; Zachary J Sapinsley; Brian P Ziemba; Zachary S Clayton; Amy E Bazzoni; Nicholas S VanDongen; James J Richey; David A Hutton; Melanie C Zigler; Andrew P Neilson; Kevin P Davy; Douglas R Seals Journal: Hypertension Date: 2021-05-10 Impact factor: 9.897